Not sure if anyone would have any insights into this... But if...

Not sure if anyone would have any insights into this...

But if Henry Schein is already a distributor of FebriDx in Europe, would you not expect that they would be a distributor in the US? What possible reason would there be for the two parties not to continue their partnership into what is such a massive market?

Maybe this is part of the sell down? Investors thinking that if this is not happening, there must be a problem. Hopefully, the webinar that has been hinted at this week sheds some positive light on where we are at with things.